James Maher, MD
Medical Oncologist
Laryngeal Cancer Lung Cancer Ovarian Cancer Pericardial Mesothelioma Peritoneal Mesothelioma Pleural Mesothelioma Testicular Mesothelioma
Biological Therapy/Immunotherapy Chemotherapy Gene Therapy Pain Management Targeted Therapy
University of Oklahoma College of Medicine
Medical School
Jewish Hospital of Cincinnati
Residency
Ohio State University Hospital
Fellowship
American Board of Internal Medicine - Oncology
OH State Medical License Active through 2018
Randomized phase II adjuvant trial of dose-dense docetaxel before or after doxorubicin plus cyclophosphamide in axillary node-positive breast cancer.
Puhalla, S., Mrozek, E., Young, D., Ottman, S., McVey, A., Kendra, K., Merriman, N.J., Knapp, M., Patel, T., Thompson, M.E., Maher, J.F., Moore, T.D., Shapiro, C.L.; J Clin Oncol. 2008 Apr 1.
See more >>Taxanes and capecitabine in combination: rationale and clinical results.
Maher, J.F., Villalona-Calero, M.A.; Clin Breast Cancer. 2002 Jan.
See more >>Randomized phase II study of gemcitabine plus cisplatin or carboplatin [corrected], with or without cetuximab, as first-line therapy for patients with advanced or metastatic non small-cell lung cancer.
Butts, C. A., Bodkin, D., Middleman, E. L., Englund, C. W., Ellison, D., Alam, Y., Kreisman, H., Graze, P., Maher, J., Ross, H. J., Ellis, P. M., McNulty, W., Kaplan, ...; J Clin Oncol. 2007 Dec 20.
See more >>